Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.
about
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Survival of patients with hepatocellular carcinoma in the San Joaquin Valley: a comparison with California Cancer Registry data.Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum.Detection of hepatocellular carcinoma using glycomic analysis.Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.HCV-related mortality among male prison inmates in Texas, 1994-2003.Liver Transplantation for Hepatocellular Carcinoma among African Americans in the United States.Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study.Recent developments in the first detection of hepatocellular carcinomaGenetic variation in CLDN1 and susceptibility to hepatitis C virus infectionAssociation of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohortA viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.Problem of hepatocellular carcinoma in West AfricaEpidemiology and carcinogenesis of hepatocellular carcinoma.Hepatitis B and hepatocellular carcinomaGenes transactivated by hepatitis C virus core protein, a microarray assayInteractions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scaleClinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-AmericansSocial support and clinical outcomes during antiviral therapy for chronic hepatitis CNCCN clinical practice guidelines in oncology: hepatobiliary cancersAssociation of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective study.Reliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimens.The changing pattern of epidemiology in hepatocellular carcinoma.HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.Hepatocellular carcinoma: management of an increasingly common problemNational trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinomaAmbovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial.Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.Increased sialylation of site specific O-glycoforms of hemopexin in liver disease.Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes.The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.Hepatocellular carcinoma: A global view.Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.
P2860
Q30746254-29DCB882-7990-448B-8A53-CBD5CDB06A3CQ30796694-4E108206-83F0-453A-A8D8-835674053FD6Q33295308-DD53ADEF-BE1A-49BF-93E7-6E4067A07E37Q33410061-2AC9A03E-9CB2-4872-B384-411D683BD935Q33516543-1A1B1A14-63D9-41E8-BBF6-C5B3FE479D0EQ33614172-5F53CF0F-DD61-48B4-9DC5-666BCEEC9233Q33802968-23D40329-48E2-4946-8147-DA7AC6ACA726Q33871866-5A106A01-A093-4BE3-BBA9-A36DBC5AD966Q33946524-10DC91AC-B2C5-4100-B35E-9774DC89A244Q34055894-9F5DDF95-D8A7-4CD2-AC1D-5A28DC7512B2Q34064240-4C304B7D-D996-470B-98A9-24C2C7EF45E5Q34110634-7E30221A-CDE3-42BC-A754-F4B59B0BED96Q34126254-F8B39AA8-D4B3-4012-A587-209169F4629CQ34197835-8AFA8547-EDB6-484F-8926-14BB3FF2E78DQ34362542-C1818617-864F-49AB-B2B8-01F438C65BB9Q34567959-EC5A5B9C-EC62-411A-93E4-89CA681C6DE7Q34589304-BDA81106-2657-42FE-BF7B-6A398EB681A0Q34618351-1435B8B0-F239-4C90-AABA-349A9A94BFF8Q35045334-417E40BA-175B-4E35-A014-51A85F68073AQ35144499-ECE8F961-B591-4970-9E59-EB916E95B508Q35163337-14EC14F1-8067-46A1-BC5E-49889B790876Q35393471-CBBB7ACF-33B4-428C-BCA6-FD729B36DAA3Q35703937-5989A724-6653-438B-8F11-61234C111A08Q35776195-A692AE01-4290-4004-94B5-30078EB80EBEQ35906682-C628C181-0789-4DA3-8FA1-BD8D28BBD0E1Q36084797-6E537B5A-DBF6-4B93-A5A8-088BB2EA5DF2Q36496442-F0A0B32A-0135-40EA-9B6A-11B65DFE0623Q36575203-2C34E051-0D15-44C8-9A93-7BDE77EE3505Q36746503-B10DD5AF-91B0-4D9A-AB7A-8FCD5C9D09C4Q36790704-D8A1474E-3435-493C-9A0E-9ED9E9873633Q36884764-C3E9F92B-9358-4236-84B0-73EC5AC59F3CQ37031762-1BEADA77-44ED-4EE5-BC44-11CD7AC23620Q37274308-FE2DFCDE-BB13-41E0-BAC3-08C7EB749599Q37278723-E318428A-4E12-4D0F-83A7-B2CC5B56A3A6Q37281965-C01BEDB1-AF55-4EF3-9943-321DF9EDE4A0Q37356370-7963DC42-7A4D-482A-8C57-7412AF116143Q37389382-67F18C7C-9687-4696-A3F8-25F8BBFF8419Q37455611-77C11813-A9E3-4659-831C-AF644F3CEA65Q37589349-BA22A668-9D92-469A-A2D4-111C8863999DQ37622144-206FE5D3-F1D0-4F50-B6D1-0B542E6F2C1B
P2860
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@ast
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@en
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@nl
type
label
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@ast
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@en
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@nl
prefLabel
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@ast
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@en
Hepatitis C-related hepatocell ...... s: influence of ethnic status.
@nl
P2093
P2860
P50
P1476
Hepatitis C-related hepatocell ...... es: influence of ethnic status
@en
P2093
Alex S Befeler
Andre C Lyra
Andres Blei
Anna S F Lok
David H Van Thiel
Jacquelyn Fleckenstein
Khozema B Hussain
Liver Cancer Network
Luis Balart
Myron Schwartz
P2860
P304
P356
10.1111/J.1572-0241.2003.T01-1-07641.X
P407
P577
2003-09-01T00:00:00Z